Date Name Title Filing Type Shares Traded Price Total Held
Dec 13, 2013
VP Strategy and Investor Relat
VP Strategy and Investor Relat Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 30,000
Jan 02, 2013
SVP Clin Devel & Reg Affairs
SVP Clin Devel & Reg Affairs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 30,000 $21.25 44,990
Jan 02, 2013
SVP Clin Devel & Reg Affairs
SVP Clin Devel & Reg Affairs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 30,000 -- 295
Dec 14, 2012
SVP Clin Devel & Reg Affairs
SVP Clin Devel & Reg Affairs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 44,543
Dec 14, 2012
VP Regulat Dev & Med Safety
VP Regulat Dev & Med Safety Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 30,000
Oct 25, 2012
SVP & General Mgr Industrial O
SVP & General Mgr Industrial O Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 30,000 $21.92 39,568
Oct 25, 2012
SVP & General Mgr Industrial O
SVP & General Mgr Industrial O Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 30,000 -- --
Dec 16, 2011
SVP Clinical Development & Reg
SVP Clinical Development & Reg Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 45,000
Dec 14, 2010
VP, Strat and Invest Relations
VP, Strat and Invest Relations Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 30,000
Dec 14, 2010
SVP F&A, CFO, Treas & Asst Sec
SVP F&A, CFO, Treas & Asst Sec Form 4/A Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 73,734

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.